Screener
Kodiak Sciences Inc KOD Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Kodiak Sciences Inc in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211951
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $169,530 | $209,862 |
| Prepaid expenses and other current assets | 5,728 | 4,954 |
| Total current assets | 175,258 | 214,816 |
| Restricted cash | 6,184 | 6,184 |
| Property and equipment, net | 81,512 | 85,258 |
| Operating lease right-of-use asset | 34,375 | 36,606 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Kodiak Sciences Inc's cash & equivalents?
- Kodiak Sciences Inc (KOD) reported cash & equivalents of $169.53M in Q1 2026.
- How has Kodiak Sciences Inc's cash & equivalents changed year-over-year?
- Kodiak Sciences Inc's cash & equivalents increased by 22.1% year-over-year, from $138.85M to $169.53M.
- What is the long-term trend for Kodiak Sciences Inc's cash & equivalents?
- Over 5 years (2020 to 2025), Kodiak Sciences Inc's cash & equivalents has grown at a -26.0% compound annual growth rate (CAGR), from $944.4M to $209.86M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Kodiak Sciences Inc's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude